Standout Papers

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease 2013 2026 2017 2021 769
  1. Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease (2013)
    Dick de Zeeuw, Tadao Akizawa et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 6 from Science/Nature 64 standout
Sub-graph 1 of 22

Citing Papers

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
2024 Standout
SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys
2024 StandoutScience
11 intermediate papers

Works of Mark T. Houser being referenced

The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy
2014
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
2013 Standout

Author Peers

Author Last Decade Papers Cites
Mark T. Houser 629 167 71 505 273 31 1.6k
Philippe Zaoui 673 190 13 391 280 62 1.6k
Kausik Umanath 633 145 18 292 277 27 1.3k
S. M. Mauer 588 78 100 338 260 37 1.5k
Steven Harwood 380 248 48 462 129 25 1.5k
J. Floege 1007 140 39 604 154 32 2.1k
Flore Duranton 769 138 39 431 147 33 1.5k
Anneleen Pletinck 922 163 35 444 153 21 1.5k
Jesus H. Dominguez 600 81 51 725 357 65 2.0k
B. Gondouin 652 149 44 383 101 26 1.3k
Yuko Izuhara 493 157 89 304 252 33 1.4k

All Works

Loading papers...

Rankless by CCL
2026